South Africa gave the Indian Serum Institute 1 million doses of vaccine because it was not really effective



[ad_1]

South Africa gave the Indian Serum Institute 1 million doses of vaccine because it was not really effective - Photo 1.

The COVID-19 AstraZeneca / Oxford vaccine is believed to provide only minimal protection against mild or moderate infections of the South African variant in young people.

The vaccine produced by the Indian Serum Institute is a product jointly developed by the British pharmaceutical company AstraZeneca and the University of Oxford. South Africa received one million doses of the previous vaccine in early February 2021 and is scheduled to receive another 500,000 in the coming weeks.

However, the country stopped AstraZeneca’s plan to launch the COVID-19 vaccine on February 8, as a result of a recent clinical trial.

The new variant is called 501Y.V2, identified by South African geneticists late last year in Nelson Mandela Bay. This is a variant that is spreading in South Africa.

According to the sheet Economic times On February 16, an experiment by the University of the Witwatersrand (South Africa) and the University of Oxford (UK) showed that this vaccine has only minimal protection against mild or moderate infection of the African male variant in young people.

Furthermore, the researchers were unable to determine the efficacy of the vaccine in serious illness, hospitalization or risk of death, since the volunteers who participated in the study were very low in those cases.

Observers said that South Africa’s new move could have a major impact on African countries, as well as many other regions. Because it is more affordable, easier to store and transport than Pfizer’s, the AstraZeneca / Oxford vaccine is a hope for African nations.

The Indian Serum Institute does not have a statement that follows the latest information. This institute has become a key vaccine provider in recent times.

South Africa’s Health Minister Zweli Mkhize announced that it could sell the AstraZeneca vaccine, after the country halted the launch of the vaccine. South Africa has decided to vaccinate healthcare workers with Johnson & Johnson vaccines in the form of “research to develop”.

The World Health Organization (WHO) 15-2 has allowed the use vaccines Order COVID-19 AstraZeneca / Oxford in case of emergency.

[ad_2]